681808-76-4Relevant academic research and scientific papers
Hepatitis C virus inhibitors
-
Page/Page column 620, (2017/01/23)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Hepatitis C Virus Inhibitors
-
Page/Page column, (2013/05/21)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
A facile synthesis of 1-substituted cyclopropylsulfonamides
Li, Jianqing,Smith, Daniel,Wong, Henry S.,Campbell, Jeffrey A.,Meanwell, Nicholas A.,Scola, Paul M.
, p. 725 - 728 (2007/10/03)
A practical, convenient, and high-yielding three-step synthesis of cyclopropanesulfonamide and 1-substituted cyclopropanesulfonamides, starting from 3-chloropropanesulfonyl chloride, is described. Georg Thieme Verlag Stuttgart.
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 138, (2010/02/11)
Hepatitis C virus inhibitors are disclosed having the general formula (I) wherein A, R2, R3, R', B and Y are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Substituted cycloalkyl P1' hepatitis C virus inhibitors
-
Page/Page column 53, (2010/02/06)
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
